Vincerx Pharma, Inc. Total Assets
Vincerx Pharma, Inc. had Total Assets of $4.69 million as of 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2025-05-15
- 2025-03-31: Assets $4.69M.
- 2024-12-31: Assets $8.01M.
- 2024-09-30: Assets $14.95M.
- 2024-06-30: Assets $21.53M.
| Period end | Assets |
|---|---|
| 2025-03-31 | $4.69M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $8.01M 10-Q · filed 2025-05-15 |
| 2024-09-30 | $14.95M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $21.53M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $11.08M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $18.22M 10-K · filed 2025-03-27 |
| 2023-09-30 | $26.28M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $35.27M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $47.45M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $59.29M 10-K · filed 2024-03-29 |
| 2022-09-30 | $72.38M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $87.74M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $103.88M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $117.68M 10-K · filed 2023-03-28 |
| 2021-09-30 | $129.43M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $91.14M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $58.00M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $63.19M 10-K · filed 2022-03-29 |
| 2020-09-30 | $66.33M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $66.48M 10-Q · filed 2020-11-10 |
| 2020-03-31 | $66.51M 10-Q · filed 2020-05-06 |
| 2019-06-30 | $25.00K 10-K · filed 2020-09-23 |